HIV

What’s stopping major progress in the development of new drugs right now? Biotech leaders and researchers shared their thoughts.

DDN editors break down a surprising connection between microplastics and antimicrobial resistance, vitamin D for multiple sclerosis, obesity drugs updates, and more news from this week.

A new vaccination schedule pumps up the immune response to human immunodeficiency virus, overcoming a barrier that has frustrated vaccine designers.

Scientists identified specific genes that confer protection or vulnerability to various infections, pointing the way to new treatments.

Pathogens invade mucosal surfaces like the nose, but typical vaccines don't mount an immune response there. Newly engineered mucosal vaccines, however, do.

For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.

Small molecule drugs that trigger the death of cells storing latent viruses are a promising approach for treating HIV. Researchers identified a potent compound in a marine sponge — a more likely source than it may seem.  

Investigating antibodies produced by infectious diseases yields vaccines with broad-acting protection.

From excising integrated viral sequences to modifying stem cells, CRISPR offers new possibilities for developing HIV treatments.

ConserV Bioscience and eTheRNA immunotherapies collaborate on mRNA vaccines for infectious diseases